Market Overview

Chardan Capital Markets Reiterates On Medical Transcription Billing


Chardan Capital Markets reiterated a Buy rating on Medical Transcription Billing Corp (NASDAQ: MTBC) Monday with a $6.25 price target.

Analayst Keay Nakae noted that the company’s proprietary SaaS platform “provides fully-integrated services including mobile health (mHealth), electronic health records (EHR), practice management (PM), and revenue cycle management (RCM) solutions to healthcare providers in the ambulatory setting.”

The revenue management cycle service industry has been highly fragmented, according to Nakae. New regulations were seen as driving industry consolidation and the company’s “primary growth strategy is to acquire smaller revenue cycle management companies and then migrate the customers of those companies onto its more cost effective platform.”

MTBC keeps its costs low by employing approximately 2,000 people in Pakistan where the labor cost is one-tenth of the United States and 50 percent less than India. Lower labor costs have given the company a substantial cost advantage over competitors.

Nakae wrote that that integration of Omni Medical Billing Services, Practicare Medical Management and CastleRock Solutions has continued as planned following the acquisitions in 2014. Cost reductions were also achieved by the elimination of 450 sub-contractors in India and approximately 100 in the U.S.

Looking forward, Nakae expected improved margins in 2015. The analyst wanted to see a “significant reduction in operating expense” in Q1 2015 compared to Q4 2014” which could move the company toward 30 percent EBITDA margins during the second half of 2015.

Medical Transcription Billing recently traded at $2.79, up 3.34 percent.

Latest Ratings for MTBC

Aug 2020HC Wainwright & Co.MaintainsBuy
Jul 2020BenchmarkInitiates Coverage OnBuy
Jun 2020HC Wainwright & Co.UpgradesNeutralBuy

View More Analyst Ratings for MTBC
View the Latest Analyst Ratings


Related Articles (MTBC)

View Comments and Join the Discussion!

Posted-In: Chardan Capital Markets Keay NakaeAnalyst Color Reiteration Analyst Ratings

Latest Ratings

APAB of A SecuritiesMaintains23.0
COPB of A SecuritiesMaintains46.0
CXOB of A SecuritiesMaintains65.0
DVNB of A SecuritiesMaintains18.0
EOGB of A SecuritiesMaintains64.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at